Purpose: To assess normal fertilization, clinical pregnancy, and live birth rates after the use of microscopic epididymal sperm aspiration (MESA).
| INTRODUCTION
Approximately 20% of men who visit infertility clinics, excluding those who have undergone vasectomies, are azoospermic. 1 Azoospermia can be classified as either "obstructive" or "non-obstructive"; regardless, it is important in each case that the specific etiology of each participant be considered. 2 Varying surgical methods are available for sperm retrieval.
Testicular sperm extraction (TESE) is now used widely as a method of sperm retrieval surgery owing to its technical simplicity. There is no doubt that micro-TESE has become a standard technique for non-obstructive azoospermia (NOA). 3 Obstructive azoospermia (OA), in contrast, can be caused by a vasectomy, congenital bilateral absence of the vas deferens (CBAVD), scarring from past epididymal infections, inguinal hernia, and hydrocelectomy. The initial therapy option for these patients includes microsurgical seminal reanastomosis with surgical skill. However, this is not always plausible in cases of CBAVD, and in others, the requirements of surgical skill for reanastomosis are unattainable. In addition, the patency and pregnancy rates following microsurgical epididymovasostomy for unknown causes of epididymal obstruction are limited. Although patients with OA are good candidates for microscopic epididymal sperm aspiration (MESA) in theory, TESE is performed widely by many surgeons because less surgical skill is required. Moreover, some authors have reported that because MESA specimens contain DNA fragmentations of sperm, intracytoplasmic sperm injection (ICSI) results in poorer fertilization and pregnancy rates. 4, 5 In this study, normal fertilization, clinical pregnancy, and live birth rates for clinically considered patients with OA, in which sperm were retrieved via either MESA or TESE, was assessed retrospectively. 
| MATERIALS AND METHODS

| Patients
| Surgical procedure
The surgical procedure was performed under local anesthesia with a spermatic block under the use of a sedative by using the micropuncture method, as was previously described (MESA group). 6, 7 Micropipette tips, which were sharpened to a diameter of ~75 μm, were connected to a 10 mL glass syringe with a silicone tube (Fig. 1) . As MESA was the primary treatment strategy for obstructive azoospermia, in cases in which motile sperm were not obtained after repeated bilateral puncturing of the epididymis, conventional or micro-TESE was used (MESA/ TESE group). The aspirated or extracted samples were transferred into modified human tubal fluid (Naka Medical, Tokyo, Japan) and sent to the in vitro fertilization (IVF) laboratory for cryopreservation.
Differences between the MESA and MESA/TESE groups for average values were tested by using the F-test and the t test. The fertilization and clinical pregnancy rates were analyzed with the chi-square test.
| RESULTS
The MESA group included 71 participants and the MESA/TESE group included 89 participants. The patient characteristics of each group are shown in Table 1 . The varying etiologies of obstruction in each group can be seen in 
| DISCUSSION
Azoospermia is classified as either "OA" or "NOA," mainly according to the FSH value, testicular volume, chromosomal evaluation, and past history. Maintaining consideration of the specific etiology of the F I G U R E 1 Under the microscope, the micropipette that was sharpened to a diameter of ~75 μm was inserted directly into the epididymal tubule by using the micropuncture technique presentation in each participant is important. Although NOA is characterized as demonstrating elevated FSH and atrophic testes, no precise data exist. In the case of NOA, there is not a sufficient quantity of sperm production occurring for such to "spill over" into the ejaculate. large quantity of uncontaminated sperm for ICSI. Nevertheless, TESE is still widely applied, even in the case of the patient with OA due to its technical simplicity and lower requirements for surgical skill. However, TESE requires surgical intervention and hence carries associated risks, such as bleeding, infection, inflammation, devascularization, and the prompting of impaired testicular function, such as decreased testosterone. 9 In the 1990s, the percutaneous epididymal or testicular sperm retrieval technique was used as a minimally invasive and cost-effective method. 10, 11 Although the collection of sperm for cryopreservation via percutaneous eididymal sperm aspiration (PESA) is successful, the amount of sperm that is obtained in this fashion is limited. Even if PESA is more successful in terms of sperm harvesting in further attempts, there is an increasing risk for postsurgical complications. 12 Thus, the percutaneous approach is surely the less-invasive technique; however, this also yields a limited number of sperm to freeze and so could lead to a poor pregnancy result.
The reason for failed epididymal aspiration is related to the obstruction of the rete testis. Successful epididymal sperm retrieval can be achieved in ~70% of cases. 13 In this study, adequate motile sperm retrieval and cryopreservation was achieved in 71 of the 71 (100%) participants in the MESA group, whereas it was only completed in 59
of the 89 (66.3%) participants in the MESA/TESE group. As MESA was the primary treatment for obstructive azoospermia, there were no data collected comparing the performance of MESA and the performance of TESE without MESA. In this series, the MESA group displayed a lower LH and FSH level, larger testicular volume, and higher testosterone, as compared with the MESA/TESE group. These differences could be related to the cryopreservation rate per case between the MESA group and the MESA/TESE group.
In retrospective single-center studies, the ICSI outcomes might be better when using epididymal sperm. One study of 368 ICSI cycles in 171 patients with OA showed a significantly higher pregnancy loss rate when testicular sperm collection was attempted.
14 Recently, one study reported that in the first ICSI cycles of couples with obstructive azoospermia, the use of epididymal spermatozoa resulted in a significantly higher live birth rate than did the use of testis spermatozoa. 15 The chance of obtaining a live birth was 39%
following MESA-ICSI and 24% following TESE-ICSI. Following adjustment for the available confounders, the odds ratio for an ongoing pregnancy rate was 1.82 (98% confidence interval: 1.05-3.67) for MESA, compared to TESE.
Uncontaminated sperm can be retrieved only by MESA and there is no need for any special requirement before cryopreservation. The MESA yields high-quality sperm and allows for a reduction in the amount of laboratory work by embryologists. Previously, the authors reported that MESA that was completed by using the micropuncture technique resulted in higher fertilization and pregnancy rates. 6, 7 Thus, the advantage of MESA is that a large quantity of sperm can be cryopreserved in a single procedure for future attempts at ICSI and that a clinical pregnancy rate of 42%-60% can be achieved. 12, 16 Conversely, another study reported that a testicular sperm group exhibited an obviously higher implantation rate, with a trend toward a higher ongoing pregnancy rate and a lower miscarriage rate, in comparison with an epididymal sperm group. 17 The hypothesis for this result was that motile sperm that are randomly taken from the epididymis have a lower reproductive potential than those taken from the testicles. Moreover, since MESA specimens contain DNA fragmentations of sperm, ICSI resulted in poorer fertilization and pregnancy rates. 4, 5 However, in a meta-analysis setting, a report noted that fertilization rates varied from 45% to 72% for epididymis sperm and from 34% to 81% for testicular sperm. 18 The relative risk ratios of 1.08, 1.01, and 0.71 were described for the fertilization rate, clinical pregnancy rate, and live birth rate, respectively, for epididymal in comparison with testicular sperm. The researchers concluded that epididymal aspiration should be used in view of the possible complication of testicular damage.
In conclusion, the successful completion of MESA specimen collection does not have any special requirement, such as mincing tissue disposition. The MESA also can reduce the amount of laboratory work that is associated with collection and handling, such as that required for sperm cryopreservation. Moreover, a MESA specimen is easily applied for ICSI in cases in which the sperm is either fresh or frozenthawed. In the authors' experience, MESA is a beneficial procedure and should be given priority over TESE.
